GTBP GT BIOPHARMA INC Product Launches 8-K Filing 2023 - IND Application for GTB-3650 GT Biopharma, Inc. submitted an IND application for the development of GTB-3650, a treatment for CD33+ leukemia.Get access to all SEC 8-K filings of the GT BIOPHARMA INC